Prespecified secondary analysis of SMART-CHOICE 3 (5,506 high-risk patients after PCI and DAPT): clopidogrel vs aspirin monotherapy reduced death, MI or stroke in females (4.3% vs 9.4%; HR 0.45) but not significantly in males (4.4% vs 6.0%); no sex interaction (p=0.288).
Secondary analysisn = 5,506
Kwon et al. Clopidogrel monotherapy versus aspirin monotherapy in females and males after percutaneous coronary intervention: a sex-stratified analysis of the SMART-CHOICE 3 trial